Could Roche’s Top-Selling Drug Be Harming Women with Primary Progressive Multiple Sclerosis?
The US Food and Drug Administration (FDA) is currently reassessing the approval of Roche’s flagship drug, ocrelizumab (marketed as Ocrevus), ...
Tag: gender-specific drug effectiveness in MS
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!